Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
Nature Aging
|
June 12, 2024
Conserved epigenetic hallmarks of T cell aging during immunity and malignancy
Tian Mi, Andrew G Soerens, Shanta Alli, et al.
Urology
|
June 29, 2013
Alterations in deoxyribonucleic acid (DNA) methylation patterns of Calca, Timp3, Mmp2, and Igf2r are associated with chronic cystitis in a cyclophosphamide-induced mouse model
In-Seon Choi, Kevin Yu, Jayoung Kim, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation
Rochelle L Tiedemann, Joel Hrit, Qian Du, et al.
Genome Biology
|
January 14, 2017
Identifying aggressive prostate cancer foci using a DNA methylation classifier
Kamilla Mundbjerg, Sameer Chopra, Mehrdad Alemozaffar, et al.
Nucleic Acids Research
|
November 28, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation
Rochelle L Tiedemann, Joel Hrit, Qian Du, et al.
Oncotarget
|
March 4, 2014
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
Huili Li, Katherine B Chiappinelli, Angela A Guzzetta, et al.
Genome Research
|
December 5, 2013
Genome-wide nucleosome map and cytosine methylation levels of an ancient human genome
Jakob Skou Pedersen, Eivind Valen, Amhed M Vargas Velazquez, et al.
Oncotarget
|
February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study
Nilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2016
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Roisin M Connolly, Huili Li, Rachel C Jankowitz, et al.
Oncotarget
|
October 29, 2013
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine
John Wrangle, Wei Wang, Alexander Koch, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
Nature Aging
|
June 12, 2024
Conserved epigenetic hallmarks of T cell aging during immunity and malignancy
Tian Mi, Andrew G Soerens, Shanta Alli, et al.
Urology
|
June 29, 2013
Alterations in deoxyribonucleic acid (DNA) methylation patterns of Calca, Timp3, Mmp2, and Igf2r are associated with chronic cystitis in a cyclophosphamide-induced mouse model
In-Seon Choi, Kevin Yu, Jayoung Kim, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation
Rochelle L Tiedemann, Joel Hrit, Qian Du, et al.
Genome Biology
|
January 14, 2017
Identifying aggressive prostate cancer foci using a DNA methylation classifier
Kamilla Mundbjerg, Sameer Chopra, Mehrdad Alemozaffar, et al.
Nucleic Acids Research
|
November 28, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation
Rochelle L Tiedemann, Joel Hrit, Qian Du, et al.
Oncotarget
|
March 4, 2014
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
Huili Li, Katherine B Chiappinelli, Angela A Guzzetta, et al.
Genome Research
|
December 5, 2013
Genome-wide nucleosome map and cytosine methylation levels of an ancient human genome
Jakob Skou Pedersen, Eivind Valen, Amhed M Vargas Velazquez, et al.
Oncotarget
|
February 11, 2017
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study
Nilofer S Azad, Anthony El-Khoueiry, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2016
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Roisin M Connolly, Huili Li, Rachel C Jankowitz, et al.
Oncotarget
|
October 29, 2013
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine
John Wrangle, Wei Wang, Alexander Koch, et al.
Page
of 17